ALS患者延髓功能障碍的临床评估方法
Clinical Assessment of Medullary Dysfunction in Amyotrophic Lateral Sclerosis Patients
DOI: 10.12677/ACM.2023.13122846, PDF,    科研立项经费支持
作者: 陈高峰:三峡大学基础医学院,湖北 宜昌;三峡大学第一临床医学院神经内科,湖北 宜昌;魏 钧*:三峡大学第一临床医学院神经内科,湖北 宜昌
关键词: 肌萎缩侧索硬化症延髓功能障碍临床评估Amyotrophic Lateral Sclerosis Bulbar Dysfunction Clinical Evaluation
摘要: 肌萎缩侧索硬化症(Amyotrophic lateral sclerosis, ALS)是一种累及上、下运动神经元的神经系统变性疾病,患者多数表现为进行性四肢无力和萎缩、延髓功能麻痹和锥体束征。95%的病人通常会在发病5年之内死亡,病程进展迅速。肌萎缩侧索硬化症的患者除了躯体运动功能活动受限外,延髓功能障碍是肌萎缩侧索硬化症的一个显著特征,它影响着患者的生存和生活质量。因此,早期诊断识别出患者存在球部功能障碍,从而及早改善患者球部功能障碍所导致的生活质量下降是目前研究迫切需要解决的问题。
Abstract: Amyotrophic lateral sclerosis (ALS) is a degenerative neurological disease involving upper and lower motor neurons. Most patients present with progressive limb weakness and atrophy, bulbar paralysis, and pyramidal tract sign. 95% of patients usually die within five years of onset, and the disease progresses rapidly. In addition to physical motor function limitation in ALS patients, bulbar dysfunction is a prominent feature of ALS, which affects the survival and quality of life of patients. Therefore, early diagnosis and identification of patients with bulb dysfunction, so as to improve the quality of life of patients with bulb dysfunction as soon as possible is an urgent problem to be solved in current research.
文章引用:陈高峰, 魏钧. ALS患者延髓功能障碍的临床评估方法[J]. 临床医学进展, 2023, 13(12): 20220-20226. https://doi.org/10.12677/ACM.2023.13122846

参考文献

[1] Maksymowicz-Sliwinska, A., Lule, D., Nieporecki, K., et al. (2023) The Quality of Life and Depression in Primary Caregivers of Patients with Amyotrophic Lateral Sclerosis Is Affected by Patient-Related and Culture-Specific Conditions. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration, 24, 317-326. [Google Scholar] [CrossRef] [PubMed]
[2] Galvin, M., Gavin, T., Mays, I., et al. (2020) Individual Quality of Life in Spousal ALS Patient-Caregiver Dyads. Health and Quality of Life Outcomes, 18, Article No. 371. [Google Scholar] [CrossRef] [PubMed]
[3] Makkonen, T., Ruottinen, H., Puhto, R., et al. (2018) Speech Deterioration in Amyotrophic Lateral Sclerosis (ALS) after Manifestation of Bulbar Symptoms. International Journal of Language & Communication Disorders, 53, 385- 392. [Google Scholar] [CrossRef] [PubMed]
[4] Thomas, K. (2020) Percutaneous Endoscopic Gastrostomy Tube Placement in Amyotrophic Lateral Sclerosis: A Case Series with a Multidisciplinary, Team-Based Approach. Annals of Gastroenterology, 33, 1-5. [Google Scholar] [CrossRef] [PubMed]
[5] Hardiman, O., Al-Chalabi, A., Chio, A., et al. (2017) Amyotrophic Lateral Sclerosis. Nature Reviews Disease Primers, 3, Article No. 17071. [Google Scholar] [CrossRef] [PubMed]
[6] Peggion, C., Scalcon, V., Massimino, M.L., et al. (2022) SOD1 in ALS: Taking Stock in Pathogenic Mechanisms and the Role of Glial and Muscle Cells. Antioxidants, 11, Article 614. [Google Scholar] [CrossRef] [PubMed]
[7] Liu, T., Woo, J.A., Bukhari, M.Z., et al. (2020) CHCHD10-Regulated OPA1-Mitofilin Complex Mediates TDP-43- Induced Mitochondrial Phenotypes Associated with Frontotemporal Dementia. FASEB Journal, 34, 8493-8509. [Google Scholar] [CrossRef
[8] Candelise, N., Salvatori, I., Scaricamazza, S., et al. (2022) Mechanis-tic Insights of Mitochondrial Dysfunction in Amyotrophic Lateral Sclerosis: An Update on a Lasting Relationship. Me-tabolites, 12, Article 233. [Google Scholar] [CrossRef] [PubMed]
[9] Castellanos-Montiel, M.J., Chaineau, M. and Durcan, T.M. (2020) The Neglected Genes of ALS: Cytoskeletal Dynamics Impact Synaptic Degeneration in ALS. Frontiers in Cellular Neu-roscience, 14, Article 594975. [Google Scholar] [CrossRef] [PubMed]
[10] Chio, A., Logroscino, G., Hardiman, O., et al. (2009) Prognostic Factors in ALS: A Critical Review. Amyotrophic Lateral Sclerosis, 10, 310-323. [Google Scholar] [CrossRef] [PubMed]
[11] Elamin, M., Bede, P., Montuschi, A., et al. (2015) Predicting Prognosis in Amyotrophic Lateral Sclerosis: A Simple Algorithm. Journal of Neurology, 262, 1447-1454. ttps://doi.org/10.1007/s00415-015-7731-6
[12] Daghlas, I., Lever, T.E. and Leary, E. (2018) A Retrospective Investiga-tion of the Relationship between Baseline Covariates and Rate of ALSFRS-R Decline in ALS Clinical Trials. Amyo-trophic Lateral Sclerosis and Frontotemporal Degeneration, 19, 206-211. [Google Scholar] [CrossRef] [PubMed]
[13] Lee, J., Madhavan, A., Krajewski, E., et al. (2021) Assess-ment of Dysarthria and Dysphagia in Patients with Amyotrophic Lateral Sclerosis: Review of the Current Evidence. Muscle & Nerve, 64, 520-531. [Google Scholar] [CrossRef] [PubMed]
[14] Rooney, J., Byrne, S., Heverin, M., et al. (2015) A Multidisciplinary Clinic Approach Improves Survival in ALS: A Comparative Study of ALS in Ireland and Northern Ireland. Journal of Neurol-ogy, Neurosurgery & Psychiatry, 86, 496-501. [Google Scholar] [CrossRef] [PubMed]
[15] Jani, M.P. and Gore, G.B. (2016) Swallowing Characteristics in Amyotrophic Lateral Sclerosis. NeuroRehabilitation, 39, 273-276. [Google Scholar] [CrossRef
[16] Ngo, S.T., Wang, H., Henderson, R.D., et al. (2021) Ghrelin as a Treatment for Amyotrophic Lateral Sclerosis. Journal of Neuroendocrinology, 33, e12938. [Google Scholar] [CrossRef] [PubMed]
[17] Tomik, B. and Guiloff, R.J. (2010) Dysarthria in Amyotrophic Lateral Scle-rosis: A Review. Amyotrophic Lateral Sclerosis, 11, 4-15. [Google Scholar] [CrossRef] [PubMed]
[18] Makkonen, T., Korpijaakko-Huuhka, A., Ruottinen, H., et al. (2016) Oral Motor Functions, Speech and Communication before a Definitive Diagnosis of Amyotrophic Lateral Sclero-sis. Journal of Communication Disorders, 61, 97-105. [Google Scholar] [CrossRef] [PubMed]
[19] Waito, A.A., Valenzano, T.J., Peladeau-Pigeon, M., et al. (2017) Trends in Research Literature Describing Dysphagia in Motor Neuron Diseases (MND): A Scoping Review. Dysphagia, 32, 734-747. [Google Scholar] [CrossRef] [PubMed]
[20] Murono, S., Hamaguchi, T., Yoshida, H., et al. (2015) Evaluation of Dysphagia at the Initial Diagnosis of Amyotrophic Lateral Sclerosis. Auris Nasus Larynx, 42, 213-217. [Google Scholar] [CrossRef] [PubMed]
[21] Plowman, E.K., Tabor, L.C., Robison, R., et al. (2016) Discriminant Ability of the Eating Assessment Tool-10 to Detect Aspiration in Individuals with Amyotrophic Lateral Sclerosis. Neu-rogastroenterology & Motility, 28, 85-90. [Google Scholar] [CrossRef] [PubMed]
[22] Plowman, E.K., Watts, S.A., Robison, R., et al. (2016) Voluntary Cough Airflow Differentiates Safe versus Unsafe Swallowing in Amyotrophic Lateral Sclerosis. Dysphagia, 31, 383-390. [Google Scholar] [CrossRef] [PubMed]
[23] Tremolizzo, L., Susani, E., Lunetta, C., et al. (2014) Primitive Re-flexes in Amyotrophic Lateral Sclerosis: Prevalence and Correlates. Journal of Neurology, 261, 1196-1202. [Google Scholar] [CrossRef] [PubMed]
[24] Couratier, P., Lautrette, G., Luna, J.A., et al. (2021) Phenotypic Variability in Amyotrophic Lateral Sclerosis. Revue Neurologique, 177, 536-543. [Google Scholar] [CrossRef] [PubMed]
[25] Marin-Medina, D.S., Gaspar-Toro, J.M. and Munoz-Rosero, A.M. (2023) Clinical Examination of the Cranial Nerves. The New England Journal of Medicine, 389, 1057-1058. [Google Scholar] [CrossRef
[26] Reese, V., Das, J.M. and Al Khalili, Y. (2023) Cranial Nerve Testing. StatPearls, Treasure Island.
[27] Sonoo, M., Kuwabara, S., Shimizu, T., et al. (2009) Utility of Trapezius EMG for Di-agnosis of Amyotrophic Lateral Sclerosis. Muscle & Nerve, 39, 63-70. [Google Scholar] [CrossRef] [PubMed]
[28] Tankisi, H., Otto, M., Pugdahl, K., et al. (2013) Spontaneous Electromyo-graphic Activity of the Tongue in Amyotrophic Lateral Sclerosis. Muscle Nerve, 48, 296-298. [Google Scholar] [CrossRef] [PubMed]
[29] Risi, B., Cotti Piccinelli, S., Gazzina, S., et al. (2023) Prognostic Useful-ness of Motor Unit Number Index (MUNIX) in Patients Newly Diagnosed with Amyotrophic Lateral Sclerosis. Journal of Clinical Medicine, 12, Article 5036. [Google Scholar] [CrossRef] [PubMed]
[30] Bede, P. and Hardiman, O. (2014) Lessons of ALS Imaging: Pitfalls and Future Directions—A Critical Review. NeuroImage: Clinical, 4, 436-443. [Google Scholar] [CrossRef] [PubMed]
[31] Rajagopalan, V., Chaitanya, K.G. and Pioro, E.P. (2023) Quantita-tive Brain MRI Metrics Distinguish Four Different ALS Phenotypes: A Machine Learning Based Study. Diagnostics, 13, Article 1521. [Google Scholar] [CrossRef] [PubMed]
[32] van der Graaff, M.M., Sage, C.A., Caan, M.W.A., et al. (2011) Upper and Extra-Motoneuron Involvement in Early Motoneuron Disease: A Diffusion Tensor Imaging Study. Brain, 134, 1211-1228. [Google Scholar] [CrossRef] [PubMed]
[33] Plowman, E.K., Tabor, L.C., Wyme, J. and Pattee, G. (2017) The Evaluation of Bulbar Dysfunction in Amyotrophic Lateral Sclerosis: Survey of Clinical Practice Patterns in the Unit-ed States. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration, 18, 351-357. [Google Scholar] [CrossRef] [PubMed]
[34] Rooney, J., Burke, T., Vajda, A., et al. (2017) What Does the ALSFRS-R Really Measure? A Longitudinal and Survival Analysis of Functional Dimension Subscores in Amyo-trophic Lateral Sclerosis. Journal of Neurology, Neurosurgery & Psychiatry, 88, 381-385. [Google Scholar] [CrossRef] [PubMed]
[35] Smith, R.A., Macklin, E.A., Myers, K.J., et al. (2018) Assessment of Bulbar Function in Amyotrophic Lateral Sclerosis: Validation of a Self-Report Scale (Center for Neurologic Study Bulbar Function Scale). European Journal of Neurology, 25, 907-e66. [Google Scholar] [CrossRef] [PubMed]
[36] Smith, R., Pioro, E., Myers, K., et al. (2017) Enhanced Bulbar Function in Amyotrophic Lateral Sclerosis: The Nuedexta Treatment Trial. Neurotherapeutics, 14, 762-772. [Google Scholar] [CrossRef] [PubMed]
[37] Appel, V., Stewart, S.S., Smith, G. and Appel, S.H. (1987) A Rating Scale for Amyotrophic Lateral Sclerosis: Description and Preliminary Experience. Annals of Neurology, 22, 328-333. [Google Scholar] [CrossRef] [PubMed]
[38] Hillel, A.D., Miller, R.M., Yorkston, K., et al. (1989) Amy-otrophic Lateral Sclerosis Severity Scale. Neuroepidemiology, 8, 142-150. [Google Scholar] [CrossRef] [PubMed]
[39] Kidney, D., Alexander, M., Corr, B., et al. (2009) Oropharyngeal Dyspha-gia in Amyotrophic Lateral Sclerosis: Neurological and Dysphagia Specific Rating Scales. Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders, 5, 150-153. [Google Scholar] [CrossRef] [PubMed]
[40] Donohue, C., Tabor Gray, L., Anderson, A., et al. (2022) Discriminant Ability of the Eating Assessment Tool-10 to Detect Swallowing Safety and Efficiency Impairments. The Laryngoscope, 132, 2319-2326. [Google Scholar] [CrossRef] [PubMed]
[41] Abdelnour-Mallet, M., Tezenas Du Montcel, S., Cazzolli, P.A., et al. (2012) Validation of Robust Tools to Measure Sialorrhea in Amyotrophic Lateral Sclerosis: A Study in a Large French Cohort. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration, 14, 302-307. [Google Scholar] [CrossRef] [PubMed]
[42] Bede, P., Bokde, A., Elamin, M., et al. (2013) Grey Matter Correlates of Clinical Variables in Amyotrophic Lateral Sclerosis (ALS): A Neuroimaging Study of ALS Motor Pheno-type Heterogeneity and Cortical Focality. Journal of Neurology, Neurosurgery & Psychiatry, 84, 766-773. [Google Scholar] [CrossRef] [PubMed]
[43] Beukelman, D., Fager, S. and Nordness, A. (2011) Communication Support for People with ALS. Neurology Research International, 2011, Article ID: 714693. [Google Scholar] [CrossRef] [PubMed]
[44] Rong, P., Yunusova, Y., Wang, J., et al. (2015) Predicting Early Bulbar Decline in Amyotrophic Lateral Sclerosis: A Speech Subsystem Approach. Behavioural Neurology, 2015, Article ID: 183027. [Google Scholar] [CrossRef] [PubMed]
[45] Allison, K.M., Yunusova, Y., Campbell, T.F., et al. (2017) The Diagnostic Utility of Patient-Report and Speech-Lan- guage Pathologists’ Ratings for Detecting the Early Onset of Bulbar Symptoms Due to ALS. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration, 18, 358-366. [Google Scholar] [CrossRef] [PubMed]
[46] Rong, P., Yunusova, Y., Richburg, B. and Green, J.R. (2018) Automatic Extraction of Abnormal Lip Movement Features from the Alternating Motion Rate Task in Amyotrophic Lat-eral Sclerosis. International Journal of Speech-Lan- guage Pathology, 20, 610-623. [Google Scholar] [CrossRef] [PubMed]